StockNow
Calendar
Log in
U.S. Markets

European commission approves Roche’s (ROG SW) Susvimo for the treatment of neovascular age-related macular degeneration (NAMD)

StockNow breaking-news AI analysis

The European Commission approved Roche's Susvimo for treating neovascular age-related macular degeneration.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

US President Trump posts "Russia has unfortunately lost control of its Diesel Oil Industry due to its War with Ukraine"

Geopolitics

US President Trump, to Fox TV, says very big things are going to be happening in the not-so-distant future on Iran

FOXAFOXFed

Fed's Goolsbee (2027 Voter) says that a mix of supply and demand pressures on inflation has more impact on PCE than destination